[Epidemiological and public health aspects of inflammatory rheumatic systemic diseases]
- PMID: 11244876
- DOI: 10.1007/s001080050745
[Epidemiological and public health aspects of inflammatory rheumatic systemic diseases]
Similar articles
-
[Immunopathogenetic hypotheses in inflammatory rheumatic diseases].Internist (Berl). 2001 Feb;42(2):198-210. doi: 10.1007/s001080050744. Internist (Berl). 2001. PMID: 11244875 Review. German. No abstract available.
-
The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey.Clin Exp Rheumatol. 2012 Mar-Apr;30(2):202-7. Epub 2012 Apr 13. Clin Exp Rheumatol. 2012. PMID: 22546069
-
[Burden of illness. First routine report on socio-medical consequences of inflammatory rheumatic disease in Germany].Z Rheumatol. 2008 Mar;67(2):157-64. doi: 10.1007/s00393-007-0250-9. Z Rheumatol. 2008. PMID: 18299856 Review. German.
-
Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis.Rheumatol Int. 2018 Nov;38(11):2121-2131. doi: 10.1007/s00296-018-4124-z. Epub 2018 Aug 9. Rheumatol Int. 2018. PMID: 30094685
-
Challenges in assessing costs of rheumatoid arthritis.Case Manager. 2003 Sep-Oct;14(5):65-72; quiz 73. doi: 10.1016/s1061-9259(03)00208-x. Case Manager. 2003. PMID: 14593350 Review. No abstract available.
Cited by
-
Burden and cost of illness in patients with juvenile idiopathic arthritis.Ann Rheum Dis. 2004 Jul;63(7):836-42. doi: 10.1136/ard.2003.008516. Ann Rheum Dis. 2004. PMID: 15194580 Free PMC article.
-
[Pain reduction through physical medicine : Update on the evidence].Z Rheumatol. 2022 Jun;81(5):376-385. doi: 10.1007/s00393-022-01182-9. Epub 2022 Mar 29. Z Rheumatol. 2022. PMID: 35352178 Review. German.
-
[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 9 International classification of functioning, disability and health (ICF)].Z Rheumatol. 2014 Sep;73 Suppl 2:104-8. doi: 10.1007/s00393-014-1434-8. Z Rheumatol. 2014. PMID: 25181981 German. No abstract available.
-
Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.Pharmacoeconomics. 2005;23(4):377-93. doi: 10.2165/00019053-200523040-00007. Pharmacoeconomics. 2005. PMID: 15853437
-
[Expression analyses for rheumatoid arthritis].Z Rheumatol. 2008 Feb;67(1):17-22, 24. doi: 10.1007/s00393-007-0248-3. Z Rheumatol. 2008. PMID: 18210133 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical